Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Publications, Resources & Guidelines
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 325 - 336 items out of 338 results
ILCN article
Antibody Drug Conjugates: Diamonds in the Rough?
ILCN article
The Promise of Artificial Intelligence-Aided Pathology in Thoracic Oncology
ILCN article
Challenges of Systemic Therapy for Patients with EGFR-mutated Lung Cancer After Progression on Targeted Therapy
ILCN article
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
ILCN article
MARIPOSA-2 Post-progression Analysis Favors Amivantamab-Chemotherapy Combination
ILCN article
Can Artificial Intelligence Identify Those at High Risk and Shift the Lung Cancer Screening Paradigm?
ILCN article
Increased Biomarker Uptake Needed to Further Realize Potential of Precision Medicine
ILCN article
Could Precision Oncology Evolve to Treat Cancer Before It Develops?
ILCN article
Mounting Evidence Supporting Neoadjuvant ChemoIO Means Surgeons Must Adapt
ILCN article
More Than Ever, Surgeons Must Collaborate to Ensure Patients Receive Appropriate Care
ILCN article
A New Treatment Option for Early-Stage ALK+ NSCLC: Adjuvant Alectinib
ILCN article
LAURA Trial Defines Role of EGFR-directed Therapy in Unresectable Stage III NSCLC
Pagination
First
First page
‹
Previous page
…
21
22
23
24
25
26
27
28
29
›
Next page
Last
Last page